Press Releases Archives - Page 78 of 103 - Lupin

BSE 2297.00 NSE 2287.20

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2297.00 NSE 2287.20

Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi®

February 17, 2015

Strong Margins, Robust Profits Quarter III Results, FY 2014-15 Net Sales up 5%, EBITDA up 20%, Net Profit up 26%

February 3, 2015

Lupin Receives FDA Approval for Generic Vancocin® Capsules

February 2, 2015

Lupin launches Generic DIOVAN® Tablets

January 6, 2015

Lupin Receives Tentative Approval for Generic Prezista® Tablets

December 30, 2014

Lupin Receives FDA Approval for Generic Epivir® Tablets

December 26, 2014

Lupin Launches Authorized Generic for Celebrex® Capsules

December 11, 2014

Lupin Receives FDA Approval for Generic Celebrex® Capsules

November 3, 2014

Quarter II Results, FY 2014-15

October 28, 2014

Lupin Announces Strategic Alliance for Emerging Markets

September 16, 2014

1 2 … 77 78 79 … 102 103

Search

Hit enter to search or ESC to close